Oral Semaglutide-Reference-Cited by-同舟云学术

Oral Semaglutide

Published:2020-01-01 Issue:1 Volume:38 Page:109-111
ISSN:0891-8929
Container-title:Clinical Diabetes
language:en
Short-container-title:

Author:

Hughes Sally¹,Neumiller Joshua J.¹

Affiliation:

1. College of Pharmacy and Pharmaceutical Sciences, Washington State University, Spokane, WA

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://diabetesjournals.org/clinical/article-pdf/38/1/109/501372/109.pdf

Reference9 articles.

1. Rybelsus (semaglutide) tablets [prescribing information];Novo Nordisk,2019

2. 9. Pharmacologic approaches to glycemic treatment: Standards of Medical Care in Diabetes—2019;American Diabetes Association;Diabetes Care,2019

3. Novo Nordisk. Rybelsus (semaglutide tablets), the first GLP-1 in a tablet approved in the US. Available from www.novonordisk.com/bin/getPDF.2172050.pdf. Accessed 9 October 2019

4. Incretin-based therapies;Neumiller;Med Clin North Am,2015

5. Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist;Buckley;Sci Transl Med,2018

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pharmacologic management for polycystic ovary syndrome: Weight loss;Polycystic Ovary Syndrome;2024

2. Perioperative management of long-acting glucagon-like peptide-1 (GLP-1) receptor agonists: concerns for delayed gastric emptying and pulmonary aspiration;British Journal of Anaesthesia;2024-01

3. Effect of Swallow Balloon Therapy with the Combination of Semaglutide Oral Formulation: a Randomised Double-Blind Single-Centre Study;Obesity Surgery;2023-12-13

4. The benefits of GLP1 receptors in cardiovascular diseases;Frontiers in Clinical Diabetes and Healthcare;2023-12-08

5. Universal Prior Authorization Template for glucagon like peptide-1 based anti-obesity medications: An Obesity Medicine Association proposal;Obesity Pillars;2023-12